Learn More
ATCC Respiratory Exclusivity Panel
Supplier: ATCC MP37
This panel of seven quantitative genomic and synthetic nucleic acid preparations was selected from respiratory pathogen strains commonly cited in exclusivity or cross-reactivity studies in SARS-CoV-2 EUA submissions and/or FDA 510(k) submissions.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.